DIGITAL EDITIONS

April-June 2026 Supplement

April-June 2026

January-March 2026

October–December 2025

Current Issue: April–June 2026

Letters to the Editor: Navigating Desire and Danger: Examining Sexual Violence Vulnerabilities Among Men Who Have Sex With Men and the LGBTQ+ Community on Dating Apps

Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: Dating apps and other social networks (DSN) that allow individuals to look for love and romance have fundamentally changed the big picture of the

Letters to the Editor: Nocturnal Tactile and Visual Hallucinations Associated with Clonidine Use

Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: Clonidine is a central acting alpha-2 receptor agonist used for the treatment of psychiatric disorders and sleep difficulties. We report a pediatric patient who

Letters to the Editor: Response to “Validation of a Pediatric Cognitive Assessment Tool to Advance Knowledge on Children’s Cognitive Development, Health Risk Factors, and Health-Promoting Interventions in Sub-Saharan Regions”

Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: We read with great interest the study by Di Cesare et al,1 which introduces the Cognitive Assessment Tool for Pediatric Clinical Research (CAT-PCR), a

Letters to the Editor: Responding to Correspondence on “Validation of a Pediatric Cognitive Assessment Tool to Advance Knowledge on Children’s Cognitive Development, Health Risk Factors, and Health-Promoting Interventions in Sub-Saharan Regions”

Dear Editor: We would like to thank the readers for their thoughtful and constructive comments on our study.1 We believe these observations are highly valuable in guiding test developers in

Letters to the Editor: Medical Errors in Psychiatry: The Case for a Global Perspective

Dear Editor: I read with great interest the article by Pope, “An Overview of Medical Errors in Psychiatry, Part 1: Introduction,”1 published in the January–March 2026 issue of Innovations in

Lessons Learned from Drug Development Programs in Autism: Implications for Future Programs

Innov Clin Neurosci. 2026;23(4–6):10–17. by Gahan Pandina, PhD; William J. Martin, PhD; Christopher Chatham, PhD; Declan Murphy, MD; Jane Myles, MSc; Robert H. Ring, PhD; and Amir Kalali, MD Dr.

Stroke Classification in Brain CT Images Using Transfer Learning With Fastai

Innov Clin Neurosci. 2026;23(4–6):18–36. by Shilpa Bajaj, MCA; Manju Bala, PhD; and Mohit Angurala, PhD Dr. Bajaj is with Applied Sciences (Computer Applications), I.K. Gujral Punjab Technical University, Kapurthala, Punjab,

Managing Sensory Impairments and Communication Differences in Psychotic Disorders

Innov Clin Neurosci. 2026;23(4–6):37–39. by Dominic Theodore, MD, MS; and Nita Bhatt, MD, MPH, DFAPA Dr. Theodore is with Department of Psychiatry, The Ohio State University Wexner Medical Center, Columbus,

Intravenous Ketamine for Treatment-Resistant Depression: A Case Report From a Public Hospital in Argentina

Innov Clin Neurosci. 2026;23(4–6):40–43. By Micaela Dines, MD; Paloma Bamondez, MD; Micaela Montenegro, MD; Pablo Diaz, MD; Ana Laura Ramos, LP; Irene Luis Vega; Gustavo Vazquez, MD, PhD; and Adriana

Shame: An Emotion Needing Exceptional Interventions

Innov Clin Neurosci. 2026;23(4–6):44–50. by Edmund Howe, MD, JD Dr. Howe is Professor of Psychiatry, Uniformed Services University of the Health Science, Bethesda, Maryland. FUNDING: No funding was provided for

A Narrative Review of Nutritional Interventions for Schizophrenia: A Pathway to Personalized Care

Innov Clin Neurosci. 2026;23(4–6):51–55. by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu, Japan and the Graduate School of

PSYCHIATRY

Validation of a Clinical Decision Support Tool for Quantifying Risk of Torsades de Pointes in a Psychiatric Inpatient Population

by Samara White, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN Drs. White

Measurement-based Care Training Curriculum in Psychiatry Residency Programs: Four-year Implementation Experience and Future Directions

by Ahmed Aboraya, MD, DrPH; Daniel Elswick, MD; James Berry, DO; Dilip Chandran, MD; Cheryl Hill, MD; Wanhong Zheng, MD;

Intranasal Esketamine in Patients with Treatment-resistant Depression Who Have Previously Failed Transcranial Magnetic Stimulation: A Case Series

by Rabeel Ahmad, DO; Samantha Shor, DO; Genesy Aickareth, BS; Roselyn Chiyezhan, BS; Meghna Mathews, BS; Isabel Chacko, BS; Brett

NEUROLOGY

Outcome of Ischemic Stroke at Six Months with Neuroglobin as a Marker

by Yetty Ramli, MD, SpN(K); Fadhlan Rusdi, MD, SpN; Mohammad Kurniawan, MD, SpN(K); Mohamad Sadikin, MD, DSc; and Florencia Evelyn,

Analysis of Levels of Vitamin D, Beta-Amyloid 42, Indoxyl Sulfate, and Serum Parathyroid Hormone in Hemodialysis Patients with Cognitive Impairment

by Prof. Yuliarni Syafrita, Sp.N(K); Harnavi Harun, Sp.PD-KGH, FINASIM; Restu Susanti, Sp.S(K) M. Biomed; and Syarif Indra, Sp.N(K) Prof. Syafrita

PSYCHOLOGY

MOOD DISORDERS

MENTAL DISORDERS

ORIGINAL RESEARCH

Exploring Anticholinergic Burden in a Psychiatric Inpatient Population

Innov Clin Neurosci. 2026;23(1–3):17–22. by Kenny Nguyen, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, PMHCNS-BC, DNS,

Development of a Probiotic-Infused Carbamazepine Dosage Form

Innov Clin Neurosci. 2026;23(1–3):32–38. by Humphrey Masimba Makumbirofa, MSc; Tariro Tsitsidzashe Hluyo, BPharm; Jonathan Chaweza, BTech; Simbarashe Wandayi, MVPG, BVSc;

Validation of a Pediatric Cognitive Assessment Tool to Advance Knowledge on Children’s Cognitive Development, Health Risk Factors, and Health-promoting Interventions in Sub-Saharan Regions

Innov Clin Neurosci. 2025;22(10–12):33–51. by Franco Di Cesare, MD; Cristiana Di Carlo, MPhil; and Leonardo Di Cesare, MD All authors

Adaptation, Translation, and Validation of the Perceived Parenting Style Scale in Pakistan Using ITC Protocol

Innov Clin Neurosci. 2025;22(10–12):72–77. by Anam Shahid, PhD; Alia Asmat, PhD; and Sunny Singh, MD Dr. Shahid and Dr. Singh